Tr is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.作用机制：It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner. Tr was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes.潜在的研究应用食欲控制和饱腹感研究血糖和胰岛素敏感性研究肥胖和代谢综合征模型GLP-1受体途径调节研究Tr mechanism of action: effects on endocrine function and insulin resistance in patients with type 2 diabetes. Tirpatide is a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP-1) receptor agonist approved in the United States as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. It is under investigation for use in chronic weight management, major adverse cardiovascular events, and the management of other conditions, including heart failure with preserved ejection fraction, obesity, and non-cirrhotic non-alcoholic steatohepatitis. The Phase 3 SURPASS 1-5 clinical trial programme was designed to assess the efficacy and safety of once-weekly subcutaneously injected tir (5, 10, and 15 mg), as monotherapy or combination therapy, across a broad spectrum of people with type 2 diabetes.Use of tir in clinical studies was associated with marked reductions in glycated haemoglobin (-1.87 to -2.59%, -20 to -28 mmol/mol) and body weight (-6.2 to -12.9 kg), as well as reductions in parameters commonly associated with heightened cardiometabolic risk such as blood pressure, visceral adiposity, and circulating triglycerides. In SURPASS-2, these reductions were greater than those with the GLP-1 receptor agonist se 1 mg. Tir was well tolerated, with a low risk of hypoglycaemia when used without insulin or insulin secretagogues, and showed a generally similar safety profile to the GLP-1 receptor agonist class. Accordingly, evidence from these clinical trials suggests that tr offers a new opportunity for the effective lowering of glycated haemoglobin and body weight in adults with type 2 diabetes.
产品展示
分析报告
客户反馈
工厂介绍
Shanghai Rise & Shine New Materials Co. LTDisa national high-tech enterprise deeply rooted in the biopolypeptide sector, specializing in the R&D, production, sales, and full-chain services of peptide products. We are committed to empowering the health and beauty industries with independent innovative technologies.核心定位与使命We focus on the core biopolypeptide track and build a complete industrial chain from raw material R&D to end-user applications, covering diverse scenarios such as pharmaceuticals, functional foods and health products, and cosmetics.秉承“技术自主、品质第一”的理念，以“让生物肽造福更多人”为使命，努力将“中国肽”推向全球市场。质量控制与市场布局我们严格执行全面的质量管理体系：从原材料采购、生产过程到产品检验的每一个环节都受到严格控制，确保产品的高质量和稳定性。全球市场布局：我们的产品销往多个国家和地区，赢得了全球客户的广泛认可和信任。坚持“质量第一、客户至上”的原则：以客户需求为中心，提供个性化产品定制和解决方案，满足多样化需求。If you′re looking for a reliable and effective solution to support your weight management journey, Shanghai Rise & Shine New Materials Co. LTD is your trusted partner. Contact us today to learn more about our products and how they can help you achieve your goals.
送货：We have our own delivery channels, and we are responsible for customs clearance and 100% delivery of the goods to your doorstep.(FedEx/USPS/UPS/DHL by air or sea)
支付：Paypal、西联汇款、银行转账、比特币和 USDT。
高品质，有竞争力的价格，充足的库存和快速交货有竞争力的价格。
送货及付款
送货：We have our own delivery channels, and we are responsible for customs clearance and 100% delivery of the goods to your doorstep.(FedEx/USPS/UPS/DHL by air or sea)
With the mission of "technological innovation drives a healthy future" ,the company is committed to developing highly active and safe peptide products through cutting-edge biotechnology, covering many fields such as cosmetics, health foods, and medicine.依托自主研发的核心技术、严格的质量管理体系和全球市场。
